Search results
Author(s):
Gregg C Fonarow
,
Tariq Ahmad
,
Harriette Van Spall
Added:
2 years ago
Dr Harriette Van Spall (McMaster University, CA) talked with Dr Gregg C Fonarow (University of California, US) and Dr Tariq Ahmad (Yale School of Medicine, US) about the PROMPT-HF trial (NCT04514458) presented first at ACC.22.
PROMPT-HF compared the efficacy of an electronic health record-based alert informing providers about evidence-based medications for HFrEF versus usual care in outpatient…
View more
Ken Okumura
Author
Author(s):
Pradeep Natarajan
Added:
5 years ago
Dr Pradeep Natarajan (Massachusetts General Hospital, Boston, US) discusses AHA cholesterol guidelines.
Filmed by Radcliffe Cardiology on site AHA 2018.
View more
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
2 years ago
Prof Nicolas Van Mieghem & Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) discuss someof the late-breaking trials from EuroPCR 2021.
View more
Author(s):
Carsten W Israel
Added:
4 years ago
This video, recorded in German features a presentation from Carsten Israel on 'What have we learned from the registries and studies for clinical practice?'
View more
Author(s):
Tiny Jaarsma
Added:
1 year ago
In this short interview, Prof Tiny Jaarsma (University of Linköping & Linköping University Hospital, SE) talks about the recently published Chronic & Acute HF Guidelines for Patients.
Talking Points:
1. Background to Chronic & Acute HF Guidelines for Patients
2. Utilisation of Patient Guidelines
3. Patient Adherence
Recorded at Heart Failure 2022, Madrid.
Videographers: Mike Knight & Tom Green…
View more
Author(s):
Anna E Platek
,
Anna Hrynkiewicz-Szymanska
,
Karolina Semczuk
,
et al
Added:
3 years ago
Topic: 4. Arrhythmias
Introduction and Objectives
Atrial fibrillation (AF) patients can be managed with rate control and rhythm control strategies. Both seem to be equally safe and effective, and the decision should be made depending on patients and doctors’ preferences.1 The aim of the study was to compare patients with persistent AF in whom rhythm control strategy is chosen to those with…
View more
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
2 years ago
In the latest episode View from the Thoraxcenter, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) review selected hot line and late-breaking trials presented atESC Congress 2021.
What are the most interesting trial concepts? What are the surprises? How should we understand the new data in context and what questions remain?
View more
Author(s):
Harriette Van Spall
,
Ganesan Karthikeyan
Added:
1 year ago
ESC Congress 22 — Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) invited Dr Ganesan Karthikeyan (All India Institute of Medical Sciences, IN) to share the latest data from the INVICTUS trial (NCT02832544).
This randomized, open-label, non-inferiority trial compared rivaroxaban (Xarelto, Bayer) versus standard vitamin K antagonists (VKA) (Warfarin) therapy in 4,500 patients…
View more
Author(s):
Harriette Van Spall
,
Added:
2 years ago
Dr Alexander J Blood (Brigham and Women's Hospital, Boston, MA, US) joins Late-breaker host Dr Harriette Van Spall (McMaster University, Hamilton, CA) to talk about the Digital Care Transformation study.
The study enrolled 10,000 patients in a remote algorithm-based cardiovascular risk management program to improve lipid and hypertension control.
Recorded remotely from Boston and Hamilton, 2021…
View more